Covista (CVSA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
CVSA dips 0.4% to $126.75. Closed at $126.75, -0.39% vs the prior close of $127.24. Day range $125.07–$128.20, opened at $126.93.
CVSA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CVSA dips 0.4% to $126.75
- Closed at $126.75, -0.39% vs the prior close of $127.24. Day range $125.07–$128.20, opened at $126.93.
- Volume was 339.55K shares, 1.0x its 50-day average of 349.98K.
- Price is -1.3% vs its 50-day average ($128.40) and +6.7% vs its 200-day average ($118.78).
- 52-week range $86.97–$156.26; today's close sits at 57% of that range, 18.9% below the 52-week high.
Oct 15, 2026 — CVSA dips 1.7% to $127.24
- Closed at $127.24, -1.73% vs the prior close of $129.48. Day range $126.97–$131.70, opened at $131.55.
- Volume was 358.10K shares, 1.0x its 50-day average of 348.30K.
- Price is -0.9% vs its 50-day average ($128.35) and +7.2% vs its 200-day average ($118.67).
- 52-week range $86.97–$156.26; today's close sits at 58% of that range, 18.6% below the 52-week high.
Oct 14, 2026 — CVSA ends flat (+0.3%) to $129.48
- Closed at $129.48, +0.26% vs the prior close of $129.14. Day range $127.51–$130.48, opened at $128.15.
- Volume was 284.80K shares, 0.8x its 50-day average of 347.23K.
- Price is +0.9% vs its 50-day average ($128.39) and +9.2% vs its 200-day average ($118.55).
- 52-week range $86.97–$156.26; today's close sits at 61% of that range, 17.1% below the 52-week high.
Oct 13, 2026 — CVSA ends flat (+0.2%) to $129.14
- Closed at $129.14, +0.21% vs the prior close of $128.87. Day range $128.63–$131.80, opened at $130.80.
- Volume was 268.70K shares, 0.8x its 50-day average of 347.55K.
- Price is +0.6% vs its 50-day average ($128.40) and +9.0% vs its 200-day average ($118.43).
- 52-week range $86.97–$156.26; today's close sits at 61% of that range, 17.4% below the 52-week high.
Oct 12, 2026 — CVSA dips 0.4% to $128.87
- Closed at $128.87, -0.39% vs the prior close of $129.38. Day range $127.48–$129.91, opened at $127.48.
- Volume was 213.80K shares, 0.6x its 50-day average of 350.22K.
- Price is +0.4% vs its 50-day average ($128.36) and +8.9% vs its 200-day average ($118.30).
- 52-week range $86.97–$156.26; today's close sits at 60% of that range, 17.5% below the 52-week high.
Oct 9, 2026 — CVSA dips 0.7% to $129.38
- Closed at $129.38, -0.70% vs the prior close of $130.29. Day range $127.00–$131.97, opened at $130.50.
- Volume was 195.90K shares, 0.6x its 50-day average of 353.22K — lighter than usual.
- Price is +0.9% vs its 50-day average ($128.28) and +9.5% vs its 200-day average ($118.18).
- 52-week range $86.97–$156.26; today's close sits at 61% of that range, 17.2% below the 52-week high.
Oct 8, 2026 — CVSA rises 2.3% to $130.29, a 1-month high
- Closed at $130.29, +2.35% vs the prior close of $127.30. Day range $127.04–$131.23, opened at $127.04.
- Volume was 226.60K shares, 0.6x its 50-day average of 356.73K.
- Price is +1.6% vs its 50-day average ($128.22) and +10.4% vs its 200-day average ($118.04).
- 52-week range $86.97–$156.26; today's close sits at 63% of that range, 16.6% below the 52-week high.
Oct 7, 2026 — CVSA ends flat (-0.1%) to $127.30
- Closed at $127.30, -0.05% vs the prior close of $127.37. Day range $126.58–$128.97, opened at $128.00.
- Volume was 267.30K shares, 0.7x its 50-day average of 358.32K.
- Price is -0.8% vs its 50-day average ($128.29) and +8.0% vs its 200-day average ($117.89).
- 52-week range $86.97–$156.26; today's close sits at 58% of that range, 18.5% below the 52-week high.
Oct 6, 2026 — CVSA rises 1.6% to $127.37
- Closed at $127.37, +1.58% vs the prior close of $125.39. Day range $125.22–$127.64, opened at $125.64.
- Volume was 219.60K shares, 0.6x its 50-day average of 358.69K.
- Price is -0.7% vs its 50-day average ($128.27) and +8.2% vs its 200-day average ($117.76).
- 52-week range $86.97–$156.26; today's close sits at 58% of that range, 18.5% below the 52-week high.
Oct 5, 2026 — CVSA ends flat (-0.1%) to $125.39
- Closed at $125.39, -0.07% vs the prior close of $125.48. Day range $124.80–$126.79, opened at $125.00.
- Volume was 408.20K shares, 1.2x its 50-day average of 354.92K.
- Price is -2.1% vs its 50-day average ($128.13) and +6.6% vs its 200-day average ($117.62).
- 52-week range $86.97–$156.26; today's close sits at 55% of that range, 19.8% below the 52-week high.
Oct 2, 2026 — CVSA rises 1.8% to $125.48, 4 up days in a row
- Closed at $125.48, +1.75% vs the prior close of $123.32. Day range $124.28–$126.96, opened at $125.17.
- Volume was 296.50K shares, 0.8x its 50-day average of 354.66K.
- Price is -1.9% vs its 50-day average ($127.94) and +6.8% vs its 200-day average ($117.49).
- 52-week range $86.97–$156.26; today's close sits at 56% of that range, 19.7% below the 52-week high.
- That makes 4 straight gains.
- SEC filings that day: DEF 14A.
CVSA latest news & SEC filings
Every SEC filing by or about CVSA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Storms Leslie received an award of 259 shares at $127.24 (≈$32.96K) on Oct 15, 2026; now holds 259
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hill Sara had withheld for taxes 1,322 shares at $127.24 (≈$168.21K) on Oct 15, 2026; now holds 8,954
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chiu Emily C received an award of 259 shares at $127.24 (≈$32.96K) on Oct 15, 2026; now holds 259
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 9, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Beard, Stephen W. sold 3,639 shares at $130.37 (≈$474.41K) on Oct 8, 2026; now holds 473,825
- Beard, Stephen W. sold 4,667 shares at $130.77 (≈$610.30K) on Oct 9, 2026; now holds 469,158
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 2, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Oct 2, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 2, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $1.95B (prior year $1.79B) (+9.3% vs Jun 30, 2025)
- Net income: $251.57M (prior year $237.06M) (+6.1% vs Jun 30, 2025)
- Diluted EPS: $7.04 (prior year $6.18) (+13.9% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CVSA
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Jan 28, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.18% (largest 2.7%).
- Liquidity: about 336.78K shares (≈$42.69M) trade per day on average.
- 52-week position: $126.75 vs a range of $86.97–$156.26 (57% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Manjunath Gangadharan sold 1,802 shares on Aug 27, 2026.
- Latest filings: 8-K Sep 23, 2026; 10-K Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 34.04M shares outstanding (Jul 31, 2026), -5.3% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Educational Services.
CVSA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 126.93 | 128.20 | 125.07 | 126.75 | 339.55K |
| Oct 15, 2026 | 131.55 | 131.70 | 126.97 | 127.24 | 358.10K |
| Oct 14, 2026 | 128.15 | 130.48 | 127.51 | 129.48 | 284.80K |
| Oct 13, 2026 | 130.80 | 131.80 | 128.63 | 129.14 | 268.70K |
| Oct 12, 2026 | 127.48 | 129.91 | 127.48 | 128.87 | 213.80K |
| Oct 9, 2026 | 130.50 | 131.97 | 127.00 | 129.38 | 195.90K |
| Oct 8, 2026 | 127.04 | 131.23 | 127.04 | 130.29 | 226.60K |
| Oct 7, 2026 | 128.00 | 128.97 | 126.58 | 127.30 | 267.30K |
| Oct 6, 2026 | 125.64 | 127.64 | 125.22 | 127.37 | 219.60K |
| Oct 5, 2026 | 125.00 | 126.79 | 124.80 | 125.39 | 408.20K |
| Oct 2, 2026 | 125.17 | 126.96 | 124.28 | 125.48 | 296.50K |
| Oct 1, 2026 | 123.41 | 125.37 | 122.37 | 123.32 | 363.50K |
| Sep 30, 2026 | 120.26 | 123.60 | 118.63 | 122.20 | 350.20K |
| Sep 29, 2026 | 116.59 | 120.68 | 116.59 | 119.45 | 403.80K |
| Sep 28, 2026 | 120.55 | 120.55 | 117.29 | 117.51 | 670.10K |
| Sep 25, 2026 | 124.31 | 124.31 | 120.70 | 120.75 | 525.90K |
| Sep 24, 2026 | 123.80 | 125.89 | 122.73 | 124.16 | 407.30K |
| Sep 23, 2026 | 122.27 | 124.42 | 121.09 | 123.19 | 260.90K |
| Sep 22, 2026 | 127.00 | 127.20 | 122.14 | 123.00 | 428.10K |
| Sep 21, 2026 | 127.28 | 127.28 | 124.01 | 125.79 | 246.70K |
About Covista
Covista (CVSA) is listed on the NYSE and classified by the SEC under “Services-Educational Services”. Its business address is in CHICAGO, IL. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 730464.
CVSA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William W Burke | Director | Nov 14, 2025 |
| Emily C Chiu | Director | Aug 19, 2026 |
| Donna J Hrinak | Director | Nov 14, 2025 |
| Georgette D. Kiser | Director | Nov 14, 2025 |
| William V Krehbiel | Director | Nov 14, 2025 |
| Michael W Malafronte | Lead Independent Director | Sep 1, 2026 |
| Sharon O'Keefe | Director | Nov 14, 2025 |
| Kenneth J Phelan | Director | Nov 14, 2025 |
| Leslie Storms | Director | Aug 19, 2026 |
| Betty M. Vandenbosch | Director | Nov 14, 2025 |
| Lisa W Wardell | Director | Nov 14, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | Aug 25, 2026 |
| Stephen W. Beard, | Chairman & CEO | Aug 25, 2026 |
| Michael Betz | Pres. Walden University & CDO | Aug 25, 2026 |
| Karen Sue Cox | President, Chamberlain Univ. | May 12, 2026 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | Aug 28, 2026 |
| Maurice Herrera | SVP - Chief Marketing Officer | Nov 14, 2025 |
| Sara Hill | CHRO | Nov 14, 2025 |
| Scott Liles | President, Medical and Vet | Apr 16, 2026 |
| Amelia Manning | President, Chamberlain Univ. | Jul 16, 2026 |
| Megan Noel | Chief Corp. Affairs Officer | Nov 14, 2025 |
| Robert J. Phelan | Chief Financial Officer | Aug 25, 2026 |
| Evan Trent | President, Adtalem Elevate | Nov 14, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Manjunath Gangadharan | Sale | 1,802 | $137.18 |
| Aug 27, 2026 | Manjunath Gangadharan | Sale | 1,802 | $137.18 |
| Aug 27, 2026 | Manjunath Gangadharan | Sale | 1,802 | $137.18 |
| Aug 27, 2026 | Manjunath Gangadharan | Sale | 1,802 | $137.18 |
| Aug 11, 2026 | Stephen W. Beard, | Sale | 3,545 | $130.35 |
| Aug 11, 2026 | Stephen W. Beard, | Sale | 3,545 | $130.35 |
| Aug 11, 2026 | Stephen W. Beard, | Sale | 3,545 | $130.35 |
| Aug 11, 2026 | Stephen W. Beard, | Sale | 3,545 | $130.35 |
| Aug 7, 2026 | Robert J. Phelan | Sale | 2,186 | $135.15 |
| Aug 7, 2026 | Robert J. Phelan | Sale | 2,186 | $135.15 |
| Aug 7, 2026 | Robert J. Phelan | Sale | 2,186 | $135.15 |
| Aug 7, 2026 | Robert J. Phelan | Sale | 2,186 | $135.15 |
| Aug 7, 2026 | Douglas G. Beck | Sale | 4,526 | $135.81 |
| Aug 7, 2026 | Douglas G. Beck | Sale | 4,526 | $135.81 |
| Aug 7, 2026 | Douglas G. Beck | Sale | 4,526 | $135.81 |
CVSA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $1.95B | $251.57M | 7.04 | $470.42M |
| Jun 30, 2025 | $1.79B | $237.06M | 6.18 | $337.90M |
| Jun 30, 2024 | $1.58B | $136.78M | 3.39 | $295.77M |
| Jun 30, 2023 | $1.45B | $93.36M | 2.05 | $191.91M |
| Jun 30, 2022 | $1.38B | $310.99M | 6.43 | $10.60M |
Latest balance sheet: total assets $3.01B, total liabilities $1.57B, cash $406.32M (as of Jun 30, 2026).
CVSA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $124.26 |
| May 7, 2026 | 8-K Item 2.02 (results) | $117.00 |
| Jan 28, 2026 | 8-K Item 2.02 (results) | $115.92 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $141.77 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $119.23 |
| May 8, 2025 | 8-K Item 2.02 (results) | $115.88 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $102.42 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $74.99 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Educational Services
Stride (LRN)Laureate Education (LAUR)Grand Canyon Education (LOPE)TAL Education (TAL)New Oriental Education & Technology (EDU)Universal Technical Institute (UTI)Graham (GHC)Strategic Education (STRA)Perdoceo Education (PRDO)Jianzhi Education Technology (JZ)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CVSA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.